Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRSEVIMAB-ALIP Cause Poor feeding infant? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Poor feeding infant have been filed in association with NIRSEVIMAB-ALIP. This represents 1.4% of all adverse event reports for NIRSEVIMAB-ALIP.

11
Reports of Poor feeding infant with NIRSEVIMAB-ALIP
1.4%
of all NIRSEVIMAB-ALIP reports
0
Deaths
6
Hospitalizations

How Dangerous Is Poor feeding infant From NIRSEVIMAB-ALIP?

Of the 11 reports, 6 (54.5%) required hospitalization, and 1 (9.1%) were considered life-threatening.

Is Poor feeding infant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRSEVIMAB-ALIP. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does NIRSEVIMAB-ALIP Cause?

Drug ineffective (173) Respiratory syncytial virus bronchiolitis (135) Bronchiolitis (83) Incorrect dose administered (80) Respiratory syncytial virus infection (76) Pyrexia (54) Cough (45) Respiratory syncytial virus test positive (36) Extra dose administered (30) Product storage error (30)

What Other Drugs Cause Poor feeding infant?

ACETAMINOPHEN\OXYCODONE (165) OXYCODONE (155) HYDROMORPHONE (152) ACETAMINOPHEN\HYDROCODONE (149) MORPHINE (148) FENTANYL (145) OXYMORPHONE (136) ASPIRIN\OXYCODONE\OXYCODONE TEREPHTHALATE (121) BUPRENORPHINE (102) ONDANSETRON (99)

Which NIRSEVIMAB-ALIP Alternatives Have Lower Poor feeding infant Risk?

NIRSEVIMAB-ALIP vs NITAZOXANIDE NIRSEVIMAB-ALIP vs NITISINONE NIRSEVIMAB-ALIP vs NITRAZEPAM NIRSEVIMAB-ALIP vs NITRENDIPINE NIRSEVIMAB-ALIP vs NITRIC

Related Pages

NIRSEVIMAB-ALIP Full Profile All Poor feeding infant Reports All Drugs Causing Poor feeding infant NIRSEVIMAB-ALIP Demographics